GoHealth (GOCO) EBIT (2019 - 2026)

GoHealth has disclosed EBIT across 8 years of filings, most recently posting -$34.8 million for Q1 2026.

• EBIT for Q1 2026 came in at -$34.8 million, down 621.73% year-over-year; the trailing twelve-month figure through Mar 2026 was -$454.4 million (down 12534.7% YoY), and the FY2025 annual result was -$412.9 million, down 5759.25% from the prior year.
• EBIT came in at -$34.8 million for Q1 2026 at GoHealth, down from -$32.3 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $80.3 million in Q4 2024 to a low of -$287.9 million in Q3 2025.
• The 5-year median for EBIT is -$38.0 million (2023), against an average of -$50.3 million.
• Across the five-year window, EBIT tumbled 1894.89% in 2022 and surged 432.98% in 2024, its largest moves.
• GoHealth's EBIT stood at -$133.2 million in 2022, then jumped by 111.31% to $15.1 million in 2023, then soared by 432.98% to $80.3 million in 2024, then sank by 140.2% to -$32.3 million in 2025, then dropped by 7.83% to -$34.8 million in 2026.
• The last three EBIT figures came in at -$34.8 million (Q1 2026), -$32.3 million (Q4 2025), and -$287.9 million (Q3 2025), per Business Quant data.